Melief CJ - Search Results

1

The distinct role of T cell costimulation in antiviral immunity.

Welten SP, Melief CJ, Arens R. Welten SP, et al. Among authors: melief cj. Curr Opin Virol. 2013 Aug;3(4):475-82. doi: 10.1016/j.coviro.2013.06.012. Epub 2013 Jul 11. Curr Opin Virol. 2013. PMID: 23850168 Review.

2

Major histocompatibility complex class II-regulated immunity to murine leukemia virus protects against early T- but not late B-cell lymphomas.

Vasmel WL, Zijlstra M, Radaszkiewicz T, Leupers CJ, de Goede RE, Melief CJ. Vasmel WL, et al. Among authors: melief cj. J Virol. 1988 Sep;62(9):3156-66. doi: 10.1128/JVI.62.9.3156-3166.1988. J Virol. 1988. PMID: 2841468 Free PMC article.

3

Peptide-based cancer vaccines.

Melief CJ, Offringa R, Toes RE, Kast WM. Melief CJ, et al. Curr Opin Immunol. 1996 Oct;8(5):651-7. doi: 10.1016/s0952-7915(96)80081-1. Curr Opin Immunol. 1996. PMID: 8902390 Review.

4

Immunotherapy of cancer by peptide-based vaccines for the induction of tumor-specific T cell immunity.

Ressing ME, Offringa R, Toes RE, Ossendorp F, de Jong JH, Brandt RM, Kast WM, Melief CJ. Ressing ME, et al. Among authors: melief cj. Immunotechnology. 1996 Nov;2(4):241-51. doi: 10.1016/s1380-2933(96)00057-7. Immunotechnology. 1996. PMID: 9373306 Review.

5

L1-specific protection from tumor challenge elicited by HPV16 virus-like particles.

De Bruijn ML, Greenstone HL, Vermeulen H, Melief CJ, Lowy DR, Schiller JT, Kast WM. De Bruijn ML, et al. Among authors: melief cj. Virology. 1998 Oct 25;250(2):371-6. doi: 10.1006/viro.1998.9372. Virology. 1998. PMID: 9792847 Free article.

6

Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset.

Rea D, Schagen FH, Hoeben RC, Mehtali M, Havenga MJ, Toes RE, Melief CJ, Offringa R. Rea D, et al. Among authors: melief cj. J Virol. 1999 Dec;73(12):10245-53. doi: 10.1128/JVI.73.12.10245-10253.1999. J Virol. 1999. PMID: 10559341 Free PMC article.

7

Design and evaluation of antigen-specific vaccination strategies against cancer.

Offringa R, van der Burg SH, Ossendorp F, Toes RE, Melief CJ. Offringa R, et al. Among authors: melief cj. Curr Opin Immunol. 2000 Oct;12(5):576-82. doi: 10.1016/s0952-7915(00)00145-x. Curr Opin Immunol. 2000. PMID: 11007362 Review.

8

Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6.

de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ, Kenter G, Offringa R, van der Burg SH. de Jong A, et al. Among authors: melief cj. Cancer Res. 2004 Aug 1;64(15):5449-55. doi: 10.1158/0008-5472.CAN-04-0831. Cancer Res. 2004. PMID: 15289354

9

Detection of human papillomavirus (HPV) 16-specific CD4+ T-cell immunity in patients with persistent HPV16-induced vulvar intraepithelial neoplasia in relation to clinical impact of imiquimod treatment.

van Poelgeest MI, van Seters M, van Beurden M, Kwappenberg KM, Heijmans-Antonissen C, Drijfhout JW, Melief CJ, Kenter GG, Helmerhorst TJ, Offringa R, van der Burg SH. van Poelgeest MI, et al. Among authors: melief cj. Clin Cancer Res. 2005 Jul 15;11(14):5273-80. doi: 10.1158/1078-0432.CCR-05-0616. Clin Cancer Res. 2005. PMID: 16033846 Free article. Clinical Trial.

10

Distinct regulation and impact of type 1 T-cell immunity against HPV16 L1, E2 and E6 antigens during HPV16-induced cervical infection and neoplasia.

van Poelgeest MI, Nijhuis ER, Kwappenberg KM, Hamming IE, Wouter Drijfhout J, Fleuren GJ, van der Zee AG, Melief CJ, Kenter GG, Nijman HW, Offringa R, van der Burg SH. van Poelgeest MI, et al. Among authors: melief cj. Int J Cancer. 2006 Feb 1;118(3):675-83. doi: 10.1002/ijc.21394. Int J Cancer. 2006. PMID: 16108057 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

543 results

Search Page